NVO20260918P95
NVO Sep 18 2026 95.00 Put (NVO260918P00095000)
option OPRA

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.